Scrip Asks… What Does 2026 Hold For Biopharma?
Scrip Asks… What Does 2026 Hold For Biopharma? Scrip 6 February 2026 Read article
Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer
Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer PharmaTimes 18 June 2025 View news
Australia based Aravax is building out late stage manufacturing capabilities in Oxford, UK
Australia based Aravax is building out late stage manufacturing capabilities in Oxford, UK BiotechTV 21 February 2025 Watch here
Biotech Aravax establishes UK subsidiary at Oxford Science Park
Biotech Aravax establishes UK subsidiary at Oxford Science Park Insidermedia 15 November 2024 View news
Aravax Establishes Pharmaceutical Development Base on the Oxford Science Park With a Focus on Developing Manufacturing Capabilities in the UK
Aravax Establishes Pharmaceutical Development Base on the Oxford Science Park With a Focus on Developing Manufacturing Capabilities in the UK Drug Development & Delivery 14 November 2024 View news
Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy
Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy SnackSafely.com 21 May 2024 View article
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure STOCKHEAD 15 February 2024 View article
Aravax secures US$22M to close series B for peanut allergy therapy
Aravax secures US$22M to close series B for peanut allergy therapy BioWorld 29 January 2024 View news [behind a paywall]
Groundbreaking peanut allergy therapy
Groundbreaking peanut allergy therapy Food & Beverage Industry News 25 January 2024 View news
Aravax raises AU$66m for peanut allergy cure as Victoria leads the way
Aravax raises AU$66m for peanut allergy cure as Victoria leads the way Business News Australia 24 January 2024 View news
